Adiponectin, type 2 diabetes and the metabolic syndrome: Lessons from human genetic studies

Expert Reviews in Molecular Medicine

Volumn 8, Issue 27, 2006, Pages 1-12

  Vasseur, Francis ^a   Meyre, David ^b   Froguel, Philippe ^b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; CANNABINOID RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROID;

AMINO ACID SUBSTITUTION; ARTICLE; BODY WEIGHT; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; DRUG MECHANISM; EXON; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENETIC MARKER; GENETIC ORGANIZATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN GENETICS; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRON; METABOLIC SYNDROME X; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADIPONECTIN; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; HUMANS; METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33751209234     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399406000147     Document Type: Article

References (83)

1. Scherer, P.E. et al. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746-26749
2. Hu, E., Liang, P. and Spiegelman, B.M. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271, 10697-10703
3. Maeda, K. et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221, 286-289
4. Nakano, Y. et al. (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 120, 803-812
5. Saito, K. et al. (1999) Organization of the gene for gelatin-binding protein (GBP28). Gene 229, 67-73
6. Ouchi, N. et al. (1999) Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476
7. Arita, Y. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83
8. Trujillo, M.E. and Scherer, P.E. (2005) Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257, 167-175
9. Weyer, C. et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935
10. Okamoto, Y. et al. (2000) An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32, 47-50
11. Vionnet, N. et al. (2000) Genomewide search for type 2 diabetes-susceptibility genes in french whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67, 1470-1480
12. Kissebah, A.H. et al. (2000) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 97, 14478-14483
13. Fruebis, J. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98, 2005-2010
14. Yamauchi, T. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295
15. Yamauchi, T. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-946
16. Kadowaki, T. and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocr Rev 26, 439-451
17. Vasseur, F. et al. (2003) The Genetics of Adiponectin. Current Diabetes Reports 3, 151-158
18. Vasseur, F. et al. (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11, 2607-2614
19. Comuzzie, A.G. et al. (2001) The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86, 4321-4325
20. Lindsay, R.S. et al. (2003) Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 52, 2419-2425
21. Chuang, L.M. et al. (2004) Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese origin. J Clin Endocrinol Metab 89, 5772-5778
22. Hager, J. et al. (1998) A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 20, 304-308
23. Duggirala, R. et al. (1999) Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 64, 1127-1140
24. Pratley, R.E. et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 101, 1757-1764
25. Waki, H. et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278, 40352-40363
26. Gibson, F. and Froguel, P. (2004) Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 53, 2977-2983
27. Gu, H.F. et al. (2004) Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 53, Suppl 1, S31-35
28. Pollin, T.I. et al. (2005) Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 54, 268-274
29. Woo, J.G. et al. (2006) Interactions Between Noncontiguous Haplotypes in the Adiponectin Gene ACDC Are Associated With Plasma Adiponectin. Diabetes 55, 523-529
30. Hotta, K. et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126-1133
31. Daimon, M. et al. (2003) Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: The Funagata study. Diabetes Care 26, 2015-2020
32. Choi, K.M. et al. (2004) Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 61, 75-80
33. Snehalatha, C. et al. (2003) Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care 26, 3226-3229
34. Duncan, B.B. et al. (2004) Adiponectin and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 53, 2473-2478
35. Hanley, A.J. et al. (2003) Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care 26, 3219-3225
36. Fumeron, F. et al. (2004) Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: The epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 53, 1150-1157
37. Vasseur, F. et al. (2005) Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: Evidence for a role of ACDC in diabesity. Diabetologia 48, 892-899
38. Maeda, N. et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099
39. Altshuler, D. et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26, 76-80
40. Yang, W.S. et al. (2003) Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: A family-based association study. Diabetologia 46, 977-983
41. Tanko, L.B. et al. (2005) ACDC/adiponectin and PPAR-gamma gene polymorphisms: Implications for features of obesity. Obes Res 13, 2113-2121
42. Meirhaeghe, A. et al. (2000) An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 43, 1424-1428
43. Barat-Houari, M. et al. (2002) Positional candidate gene analysis of Lim domain homeobox gene (IsI-1) on chromosome 5q11-q13 in a French morbidly obese population suggests indication for association with type 2 diabetes. Diabetes 51, 1640-1643
44. Yamauchi, T. et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
45. Stefan, N. et al. (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48, 2282-2291
46. Tsuchida, A. et al. (2005) Peroxisome proliferator-activated receptor (PPAR){alpha} activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: Comparison of activation of PPAR{alpha}, PPAR{gamma}, and their combination. Diabetes 54, 3358-3370
47. Takahashi, M. et al. (2000) Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24, 861-868
48. Stumvoll, M. et al. (2002) Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: Interaction with family history of type 2 diabetes. Diabetes 51, 37-41
49. Menzaghi, C. et al. (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51, 2306-2312
50. Yang, W.S. et al. (2003) Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 81, 428-434
51. Ukkola, O. et al. (2003) Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52, 881-884
52. Vozarova de Courten, B. et al. (2005) Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54, 284-289
53. Nakatani, K. et al. (2005) Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects. Int J Mol Med 15, 173-177
54. Sutton, B.S. et al. (2005) Genetic analysis of adiponectin and obesity in Hispanic families: The IRAS Family Study. Hum Genet 117, 107-118
55. Ukkola, O. et al. (2005) Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 37, 141-150
56. Bouatia-Naji, N. et al. (2006) ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55, 545-550
57. Matsuzawa, Y. et al. (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24, 29-33
58. Lakka, H.M. et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama 288, 2709-2716
59. Shioji, K. et al. (2005) Hypoadiponectinemia implies the development of atherosclerosis in carotid and coronary arteries. J Cardiol 46, 105-112
60. Filippi, E. et al. (2005) The adiponectin gene SNP +276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age < or = 50 years). J Mol Med 83, 711-719
61. Qi, L. et al. (2005) The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54, 1607-1610
62. Bacci, S. et al. (2004) The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 27, 2015-2020
63. Ohashi, K. et al. (2004) Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43, 1195-1200
64. Lacquemant, C. et al. (2004) The adiponectin gene SNP +45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 21, 776-781
65. Zietz, B. et al. (2001) Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 109, 320-325
66. Kondo, H. et al. (2002) Association of adiponectin mutation with type 2 diabetes: A candidate gene for the insulin resistance syndrome. Diabetes 51, 2325-2328
67. Pritchard, J.K. (2001) Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69, 124-137
68. Reich, D.E. and Lander, E.S. (2001) On the allelic spectrum of human disease. Trends Genet 17, 502-510
69. Hani, E.H. et al. (1998) Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 41, 1511-1515
70. Fu, Y. et al. (2005) Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46, 1369-1379
71. Bluher, M. et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3, 25-38
72. Swinburn, B.A. et al. (1991) Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 88, 168-173
73. Landsberg, L. (2005) Insulin resistance and the metabolic syndrome. Diabetologia 48, 1244-1246
74. Savage, D. (2005) PPAR gamma as a metabolic regulator: Insights from genomics and pharmacology. Expert Rev Mol Med 7, 1-16
75. Lara-Castro, C. et al. (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55, 249-259
76. Sharma, A.M. and Tarnopolsky, M.A. (2005) Regulating adiponectin: Of flax and flux. Diabetologia 48, 1035-1037
77. Seidell, J. et al. (1988) Abdominal fat depots measured with computed tomography: Effetcs of degree of obesity, sex and age. Eur J Clin Nutr 42, 805-815
78. Ryan, A. et al. (2003) Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26, 2383-2388
79. Janigan, D. et al. (1993) Structural changes in the subcutaneous compartment in morbid obesity. Obes Res 1, 384-389
80. Heid, I.M. et al. (2006) Genetic Architecture of the APM1 Gene and Its Influence on Adiponectin Plasma Levels and Parameters of the Metabolic Syndrome in 1,727 Healthy Caucasians. Diabetes 55, 375-384
81. Hara, K. et al. (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51, 536-540
82. Populaire, C. et al. (2003) Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for Type 2 diabetes mellitus in Japanese families? Diabetologia 46, 443-445
83. Zacharova, J., Chiasson, J. and Laakso, M. (2005) The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial. Diabetes 54, 893-899